CCL2 and kidney disorder: Elevated in both human and experimental kidney diseases, MCP1 secretion is triggered by interleukin-1, tumour necrosis factor-alpha [90] and interferon-gamma [91], all of which were induced in our model by TGFβ1, yet blocked when co-applied with danegaptide.